Share this article
Share this article
ResearchAndMarkets.com's offering.
The real-world evidence solutions market is expected to grow at a CAGR of 16.5% from 2020 to 2027 to reach USD 3.13 billion by 2027.
The growth in the real-world evidence solutions market is mainly attributed to the rising geriatric population and burden of chronic diseases, the shift towards value-based care, growing focus on personalized healthcare, delays in drug development and the subsequent increase in development costs, and expanding use of RWE for regulatory decision making. Moreover, growth opportunities in emerging markets; rising focus on end-to-end RWE services; and emerging roles of wearable devices, social media, and AI in RWE provide growth opportunities for players operating in the real-world evidence solutions market.